This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Mednax Inc
MD : NYSE : Health Care
$70.04 -0.06 | -0.09%
Today's Range: 69.48 - 70.27
Avg. Daily Volume: 875,200
05/03/16 - 3:59 PM ET

Financial Analysis


MEDNAX INC's gross profit margin for the first quarter of its fiscal year 2016 is essentially unchanged when compared to the same period a year ago. Even though sales increased, the net income has decreased.

During the same period, stockholders' equity ("net worth") has increased by 16.43% from the same quarter last year.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.



Income Statement Q1 FY16 Q1 FY15
Net Sales ($mil)752.62639.4
EBITDA ($mil)143.82128.43
EBIT ($mil)124.23114.82
Net Income ($mil)67.968.71


Balance Sheet Q1 FY16 Q1 FY15
Cash & Equiv. ($mil)64.2856.99
Total Assets ($mil)4636.293646.31
Total Debt ($mil)1442.7897.16
Equity ($mil)2460.62113.23


Profitability Q1 FY16 Q1 FY15
Gross Profit Margin31.0630.71
EBITDA Margin19.120.08
Operating Margin16.5117.96
Sales Turnover0.620.69
Return on Assets7.238.83
Return on Equity13.6315.25
Debt Q1 FY16 Q1 FY15
Current Ratio0.01.79
Debt/Capital0.370.3
Interest Expense14.463.27
Interest Coverage8.5935.15


Share Data Q1 FY16 Q1 FY15
Shares outstanding (mil)93.7493.45
Div / share0.00.0
EPS0.730.72
Book value / share26.2522.61
Institutional Own % n/a n/a
Avg Daily Volume876650.0860893.0

Valuation


BUY. This stock's P/E ratio indicates a discount compared to an average of 23.33 for the Health Care Providers & Services industry and a discount compared to the S&P 500 average of 23.99. To use another comparison, its price-to-book ratio of 2.70 indicates valuation on par with the S&P 500 average of 2.74 and a discount versus the industry average of 3.38. The price-to-sales ratio is above the S&P 500 average and well above the industry average, indicating a premium. Upon assessment of these and other key valuation criteria, MEDNAX INC proves to trade at a discount to investment alternatives within the industry.


Price/Earnings
1 2 3 4 5
premium   discount
  Price/Cash Flow
1 2 3 4 5
premium   discount
MD 19.71 Peers 23.33   MD NA Peers 14.63

Discount. A lower P/E ratio than its peers can signify a less expensive stock or lower growth expectations.

MD is trading at a discount to its peers.

 

Neutral. The P/CF ratio is the stock’s price divided by the sum of the company's cash flow from operations. It is useful for comparing companies with different capital requirements or financing structures.

Ratio not available.

 
Price/Projected
Earnings
1 2 3 4 5
premium   discount
  Price to
Earnings/Growth
1 2 3 4 5
premium   discount
MD 15.38 Peers 15.76   MD 1.07 Peers 0.93

Average. An average price-to-projected earnings ratio can signify an industry neutral stock price and average future growth expectations.

MD is trading at a valuation on par with its peers.

 

Premium. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.

MD trades at a premium to its peers.

 
Price/Book
1 2 3 4 5
premium   discount
  Earnings Growth
1 2 3 4 5
lower   higher
MD 2.70 Peers 3.38   MD 10.12 Peers 62.97

Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.

MD is trading at a discount to its peers.

 

Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.

However, MD is expected to significantly trail its peers on the basis of its earnings growth rate.

 
Price/Sales
1 2 3 4 5
premium   discount
  Sales Growth
1 2 3 4 5
premium   discount
MD 2.29 Peers 0.80   MD 15.17 Peers 14.39

Premium. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.

MD is trading at a significant premium to its industry.

 

Average. Comparing a company's sales growth to its industry helps to determine if the company is adding or losing market share.

MD is keeping pace with its peers on the basis of sales growth.

 

 

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Latest Stock Upgrades/Downgrades


Top Rated Stocks Top Rated Funds Top Rated ETFs